This bodes well for UltraFlix. Netflix, MoviePass and

New Post Public Reply Private Reply Replies (0) Message Board
Schekin
1,392
This bodes well for UltraFlix.

Netflix, MoviePass and how technology is radically redefining the movie business
https://newatlas.com/netflix-moviepass-theate...ion/53426/


"As Netflix steps into blockbuster movie territory and MoviePass brings new disruptions to an old theatrical model, we're witnessing a transformative moment for the movie business. What can movie theaters do to rekindle their dwindling audiences? Is the answer in the very same technology that is threatening its existence?

The reveal of The Cloverfield Paradox on Netflix menus during the Super Bowl
Bright, costing nearly $100 million dollars was the biggest Netflix movie yet
MoviePass' app that lets subscribers know of nearby participating cinemas
In a large step into the movie business world, MoviePass made its presence known at this...
For several years, Paramount and super-producer J.J. Abrams teased a big-budget sci-fi thriller titled God Particle. Initially set for release in early 2017, the film was pushed back amidst rumors it was actually the third entry in the expanding series of unpredictable Cloverfield films.

Anticipation built over the course of 2017 until everything went quiet late in the year. Rumors began to swirl in January that Netflix was in talks with Paramount to buy the film. Then, in a remarkably paced turn of events, Netflix dropped a trailer for newly retitled Cloverfield Paradox during the Super Bowl announcing the entire film would be available to stream immediately following the game.

This was perhaps the most unconventional and unexpected blockbuster film release ever. Social media lit up, people were excited. A big budget sci-fi film, teased for years and part of a major franchise, was suddenly available to stream on Netflix with virtually no warning. Never mind that the film itself was rubbish, and unsurprisingly sold off by Paramount, Netflix had got value for money out of its investment.

The dawn of the Netflix blockbuster

In recent years Netflix has fundamentally disrupted the TV business, releasing entire seasons in one go and allowing the binge-watch model to alter the way we consume media. But the movie business had still been holding strong. After all, if you wanted to see a new film then you had to leave the house and go to a cinema.

Netflix is now setting its targets on the movie business, with plans to release over 80 original film titles in 2018 – that's almost two per week, from small independents to giant blockbusters. Last year, just a fortnight before Christmas, its biggest film to date appeared on subscribers' home menu screens. Bright, an original Netflix production, cost a reported US$90 million dollars, starred a bonafide movie star, and was promoted in advertising and on billboards like a big Hollywood blockbuster.

The film itself was not good, but maybe it didn't have to be. Unlike a traditional theatrical release, people inevitably have less investment in a Netflix film. You haven't devoted an evening to leaving the house. You haven't paid $10 to $15 for an individual ticket, and then lodged an extra bank loan to afford popcorn and drinks. Whereas bad word of mouth can destroy a film after its opening weekend, with a Netflix release it doesn't matter. All that counts is anticipation. The value is the build-up and then, once it is released, the excitement machine just moves onto the next thing. The Netflix model is to lure new subscribers and all the Bright billboards and PR would certainly have done the job.

Viewing figures for Netflix are notoriously murky, but the platform itself announced that Bright had more first week views than any of its other releases and immediately commissioned a sequel. Some estimates suggest that around 11 million people streamed the film in its first few days of release. That equates to a strong, but not spectacular, opening weekend for a theatrical film.

Bright, costing nearly $100 million dollars was the biggest Netflix movie yet
Should cinemas be worried?

Maybe…

Industry analysts freaked out last year when the US summer box office numbers were the lowest in over a decade. While some, quite fairly, pointed out that this number was most likely related to the fact that many of the blockbuster films released were total flops, the inadvertent implication raised is the key behind any potential future theatrical downfall.

Big studios are making bigger budgeted films, and they are making less of them. Long term box office grosses may be stable at the moment but all the money earned is being divided amongst fewer and fewer films. To borrow a trite, but true, aphorism – the studios are increasingly putting all their eggs into fewer baskets.

There is an implication that movie theaters are the sole reserve of big spectacle. The new Star Wars or Marvel movie is what will get people out of the house and into a theater, so this is where big Hollywood studios are putting their money. Of course, when audiences tire of those films or simply get a run of titles that are just plain bad, Netflix is there waiting with a fresh bit of content at the click of a button.

If movie theaters, and Hollywood studios, are counting on cornering the blockbuster market, then Netflix's latest move into that territory would certainly be a concern. At $90 million, Bright was a legitimate giant production and it won't be the last. As well as buying mid-budgeted titles like Cloverfield Paradox, or the upcoming Annihilation, Netflix is seriously investing in gigantic movies from the ground up.

Martin Scorsese's next film, a gangster movie called The Irishman starring Robert De Niro, Al Pacino and Joe Pesci, is being bankrolled by the streaming service to the tune of over $100 million (and rumors suggest it is climbing higher by the day). There is no announcement on whether the film will get a release in cinemas or go straight to the stream.

Can a subscription model bring audiences back into the cinema?
"We're not anti-theater"

Last year, Netflix CEO Reed Hastings suggested his company is not "anti-theater", and that people will always seek out the communal cinema experience. But Netflix is disrupting a traditional model in ways that are a little more dramatic than anything ever seen before.

It's fair to say that the movie business has been in a state of constant disruption for almost a century. In the 1950s television was going to kill cinema. In the 1980s it was video. In the 1990s it was DVD and premium cable television. So it isn't unreasonable to just see Netflix and streaming as just the latest to join this list.

Except it isn't the same. When VHS threatened to kill cinema you didn't suddenly find giant movies only released straight to video and only available at one rental store. When Netflix spends $100 million on a giant blockbuster that will never appear in a movie theater, you know something serious is going on.

Despite young millennial audiences embracing streaming subscriptions at an unprecedented rate, they are still going to see movies in theaters… for now. One suggestion behind the reason younger audiences are still going to movie theaters is that streaming services lack the blockbuster content that social media demands users have an immediate take on. Netflix's encroachment into big budget movie content seems brilliantly calibrated to corner that market.

MoviePass' app that lets subscribers know of nearby participating cinemas
Fight a disruption with a disruption

So how can movie theaters keep people coming to see movies on the big screen?

Ironically, the answer could be in yet another technological disruption that movie theaters are firmly rallying against.

MoviePass was originally founded in 2011, but it wasn't until 2016 when the co-founder of Netflix, Mitch Lowe, became the company's CEO that the service started to appeal to a wide market. For about a year Lowe experimented with different pricing structures and tiered models, but everything changed in August 2017. Data analytics firm Helios and Matheson bought a major stake in the company and, not necessarily coincidentally, a new low flat-rate subscription fee was announced. For $9.95, subscribers could see one film, every day of the month.


The plan was that of a classic Silicon Valley startup. Money would inevitably be lost initially as the company built up its bank of subscribers, but the valuable data harvested from its customers could ultimately be sold back to advertisers eagerly seeking to target key consumers.

The world's largest theater chain, AMC, was not happy and immediately threatened legal action, but quickly backed off. Charging MoviePass a full ticket price for all its subscribers, AMC chose to sit back and bide its time, recognizing that a company can only run on a major loss for so long before it ultimately goes under.

But MoviePass, despite maintaining constant major financial losses, exploded in popularity. By December it had crossed one million subscribers and then remarkably, it added another 500,000 in just the first few weeks of January 2018. As of February 9, the company crossed the two million subscriber mark.

As of early 2018, MoviePass began to flex its muscles and took its first big swing at exhibitor giant AMC. A small handful of AMC theaters were suddenly removed from its subsidized platform, with insiders believing it a ploy to get a cheaper ticket price deal from the exhibitor. Clearly MoviePass felt like it was in a strong enough bargaining position, with enough subscribers, to be able to take a gamble like this.

In late January MoviePass also teamed up with a North American distribution company to buy the theatrical rights to a new film. The plan here, one imagines, is that the company can use its app and advertising outlets to target the film to its users and drive attendance to the film. It's another fascinating new ploy.

In a large step into the movie business world, MoviePass made its presence known at this...
While MoviePass is an obvious threat to the classic exhibition model that big giants like AMC have relied on, it could also rejuvenate movie theater audiences. CEO of Helios & Matheson, Ted Farnsworth, claims that MoviePass brings people back to movie theaters.

"As we've grown our subscriber base, we've seen a dramatic increase in movie theater attendance among our subscribers, which proves to us that MoviePass is working to revitalize a declining industry," Farnsworth says.

It's an interesting idea, and one that could quite possibly appeal to a new generation of movie theater audiences. Just as Netflix banks on lower expectations for its films because people aren't paying for them individually, MoviePass plays on the same psychological gambit. The hypothesis is that when you're not individually paying for each movie, you're more likely to experiment with titles that stray off the beaten path. You may have some spare time and pop into a cinema more than just once a month for the big $100 million blockbuster. Maybe that cheap, weird indie, or the mid-budgeted drama will lure you into a cinema. MoviePass also claims that its customers are more likely to spend money on candy bar items as they haven't already shelled out directly for a ticket at the box office.

As it stands, MoviePass is not a sustainable model. How long it can keep hemorrhaging money is yet to be seen but even if it goes under in six or 12 months, the Pandora's box has been opened. Millions of customers have experienced a subscription model for movie theaters and they won't be happy moving back to the old system. Just like Spotify reframed how music is consumed, MoviePass is altering the way audiences go to see movies. The longer theaters attempt to keep a grasp on their old model, the more time Netflix will have to step in and completely consume it.

Technology may be killing the classic theatrical model, but it can also save it. In this situation resistance is not futile… it is fatal."

Nanotech Entertainment Inc. (NTEK) Stock Research Links

NTEK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 273

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 404

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 253

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 250

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 480

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 296

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 493

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 391

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 298

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms

Updated Category News Views 239

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Continue Reading

Top 5 Most Recently Viewed Articles

Market Shifts Away from Tech: Insights on Russell 2000 Stocks

Updated Category News Views 238

Indices: Mixed Signals as Investors Shift Focus US equity index futures remain steady after a recent market rotation. While the S&P 500 ended flat, the Nasdaq 100 experienced a slight decline as investors adjusted their portfolios, particularly moving away from high-profile technology stocks. However, the Dow showed resilience, bolstered by robust performance in defense...

Continue Reading
Kagurabachi Anime Unveils Star Cast and Production Team

Updated Category News Views 21

Embarking on a New Anime Adventure Kagurabachi is the latest sensation gearing up to hit the anime airwaves, and boy, does it come with quite the pedigree. This isn't just another blip on the Weekly Shonen Jump lineup. Nope, it's a full-throttle affair mean't to slash its way into our hearts—and maybe wallets, but more on that later. The Cast That Packs a Punch Miku...

Continue Reading
Introducing Lefty™: An Innovative Drink for Left-Handed Athletes

Updated Category News Views 369

Introducing Lefty™: An Innovative Drink for Left-Handed Athletes Finally, there's a sports drink that acknowledges the unique challenges faced by left-handed individuals in a world designed for right-handers. Pickle Juice® has unveiled Lefty™, a revolutionary beverage tailored to left-handed athletes, addressing issues from awkward packaging to the frustration of...

Continue Reading
Urgent Call for Governance Reforms at Grifols by Flat Footed LLC

Updated Category News Views 183

Flat Footed LLC's Concerns About Grifols' Governance Flat Footed LLC, a notable investment manager, is making headlines for urging Grifols, S.A. to reconsider its governance strategy. Holding a significant 4.64% stake in the company, Flat Footed aims to enhance transparency and align the interests of shareholders. Letter to the Board of Directors Recently, Flat Footed LLC...

Continue Reading
Piramal Pharma Limited Reports Strong Q2 and H1 FY25 Results

Updated Category News Views 176

Piramal Pharma Limited Reports Strong Q2 and H1 FY25 Results Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a prominent global pharmaceuticals and wellness entity, has outlined its standalone and consolidated results for the Second Quarter (Q2) and Half Year (H1) concluded in September 2024. The company has demonstrated impressive growth in key financial metrics,...

Continue Reading